Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
DISASTERS AVERTED — Near Miss Case Studies
When Newly Diagnosed, It’s Not Just About Taking an Injection
EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners
Eran Bashan Part 5, Partnering with Providers and Patients
HOMERUN SLIDES — Great Clinical Presentation Highlights
Diagnosing Diabetes Mellitus in Adults Part 5
CLINICAL GEMS — The Best from Diabetes Texts
MOST POPULAR ARTICLES OF THE MONTH
#1 AACE/ACE Position Statement On SGLT-2 Inhibitors and DKA Risk
#2 What is the Actual Cost of Insulin for Your Patients?
#3 Not All Neuropathies in Diabetes are Caused by Diabetes
Editor's Note
In last week’s newsletter, we were discussing the melding of drugs and medical technology together to improve patient outcomes. This will be the wave of the future as more Pharma companies enter into pay-for-performance contracts with insurers and better outcomes will be the only way they can be paid. This is already happening in some places with the use of the d-NAV system from Hygieia. Our publisher, Stephen Freed, sat down with Eran Bashan, the CEO, to find out how this marriage is working.
Your partner in diabetes care,
Dave Joffe
Editor-in-chief
DISASTERS AVERTED — Near Miss Case Studies
When starting a patient on insulin, there’s more than just teaching how to give an injection and check glucose levels. Teach insulin’s action and side effects, especially the possibility of hypoglycemia, what it is, how to prevent, recognize and treat it.
EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners
In part 5 of this Exclusive Interview, Eran Bashan explains how d-Nav works in conjunction with a doctor’s prescription and a patient’s insulin adjustment, and working with Blue Cross to reach providers.
HOMERUN SLIDES — Great Clinical Presentation Highlights
In this week’s Homerun Slides, changing the current classification of diabetes to reflect the beta-cell-centric approach.
CLINICAL GEMS — The Best from Diabetes Texts
The unique property of the pancreatic beta cell is its ability to secrete insulin to enable circulating glucose levels to be maintained within a narrow physiologic range, despite wide fluctuations in energy intake and expenditure.
MOST POPULAR ARTICLES OF THE MONTH
A year after the FDA warning, a strong response to the question: are SGLT-2 inhibitors safe?
For patients in the U.S., the price of this lifesaving treatment has risen dramatically.
Female, 57 years of age, type 2 diabetes, metformin 1,000mg twice daily for 12 years, came in with weakness, anemia, tingling of fingers and toes. Her A1C had always been below 7%. Some in my office thought she had developed diabetic peripheral neuropathy. I could not disagree, but I also knew metformin can cause vitamin B12 deficiency.